Genentech, the US biotech arm of Swiss pharma giant Roche, is building a new small-batch biologics manufacturing facility at its Oceanside campus in California, USA...
Bowing to growing pressure from activist investors with different missions, the supervisory board of tradition-steeped German pharmaceuticals and agrochemicals player...
The CEOs of seven multinational pharmaceutical companies have announced that they are taking joint action to achieve near-term emissions reduction targets and accelerate...
From next year, GSK’s top management will be led by a double female team, a pioneering move for the global pharmaceutical industry. The UK drugs giant this week announced...
Swiss drugmaker Roche has launched a genomic profiling kit that it has developed in conjunction with Foundation Medicine. The Basel-based company is supplying the kit...
Swiss drugmaker Roche has acquired Irish biotech Inflazome for €380 million, said to be one of the largest deals in Irish biotech history. Headquartered in Dublin...
UK biopharma Celleron Therapeutics has signed a licensing deal with Roche, gaining exclusive worldwide rights to the Swiss pharma’s monoclonal antibody emactuzumab, which...
Roche has announced two separate collaborations, one for an investigational cancer treatment and the other for the discovery of small molecule drugs for treating immune...
